New hematological biomarkers in patients with atrial septal aneurysm

Mean platelet volume/platelet count (MPV/PC) and monocyte/lymphocyte (MLR), neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) ratios are new hematological markers showing systemic platelet activation and inflammation. The aim of this study was to compare new hematological markers in patients with atrial septal aneurysm (ASA) and to determine their relationship in patients with ASA. 70 ASA and 47 healthy subjects (as control group) were included in the study. Demographic, clinical, echocardiographic and hematological values of the groups were recorded. MPV/PC ratio and MLR were significantly higher in ASA group compared to control group (0.03 ± 0.013 vs 0.02 ± 0.009, P=0.02 and 0.27 ± 0.15 vs 0.22 ± 0.08, P=0.03). NLR and PLR were not different between the groups. The presence of ASA was positively correlated with MLR and MPV/PC, left atrium, left ventricular (LV) septum thickness and LV posterior wall thickness, while red blood cell (RBC) was negatively correlated. However, in multivariate linear regression analysis, there was an independent relation between the presence of ASA and MPV/PC, MLR, LV septum thickness and RBC. We found that MPV/PC ratio and MLR from new hematological biomarkers are independent predictors for the presence of ASA.

PDF

___

1. Yetkin E, Atalay H, Ileri M. Ileri. Atrial septal aneurysm: prevalence and covariates in adults. Intern J Cardiol. 2016;223:656-9.

2. Mügge A, Daniel WG, Angermann C, et al: Atrial septal aneurysm in adult patients: A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91.2785.

3. Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol. 1985;6:1370-138211.

4. Gallet B, Malergue MC, Adam C, et al. Atrial septal aneurysm: a potential cause of systemic embolism. Br Heart J. 1985;53:292-7.

5. Belkin RN, Hurwitz BJ, Kisslo J. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke. 1987;18:856-62.

6. A. Kurtul, Ornek E. Platelet to lymphocyte ratio in cardiovascular diseases: a Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review. Angiology. 2019;70:802-18.

7. C.V. Serrano, F.R. De Mattos, F.G. Pitta, et al. Association between neutrophil-lymphocyte and platelet-lymphocyte ratios and coronary artery calcification score among asymptomatic patients: data from a crosssectional study. Mediators Inflamm. 2019;2019:6513847.

8. Hammadah M, Hazen SL, Tang WHW. Monocyte to lymphocyte ratio is associated with adverse long term outcomes in patients with heart failure. J Card Fail. 2016;22:32.

9. Ji H, Li Y, Fan Z, et al. Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc Disord. 2017;17:90.

10. Tian C, Song J, He D, et al. Predictive value of mean platelet volume/ platelet count for prognosis in acute myocardial infarction. Int Heart J. 2018;59:286-92.

11. Elsayed AM, Mohamed GA. Mean platelet volume and mean platelet volume/platelet count ratio as a risk stratification tool in the assessment of severity of acute ischemic stroke. Alex J Med. 2017;53:67–70.

12. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: a report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography. J Am Soc Echocardiogr. 2005:18:1440-63

13. Schneider B, Hofmann T, Meinertz T. Is there an association of atrial septal aneurysm with arrhythmias? Cardiology. 1999;91:87-91.

14. Janion M, Kurzawski J. Atrial fibrillation in patients with atrial septal aneurysm. Cardiol J. 2007;14:580-4.

15. Lip GY, Patel JV, Hughes E, Hart RG. High sensitivity C reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke. 2007;38:1229–37.

16. Shao Q, Chen K, Rha SW, Lim HE, Li G, Liu T. Usefulness of neutrophil/ lymphocyte ratio as a predictor of atrial fibrillation: a meta-analysis. Arch Med Res. 2015;46:199-206.

17. Frangogiannis NG. Regulation of the inﬂammatory response in cardiac repair. Circ Res. 2012;110:159–73.

18. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial ﬁbrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100:87–95.

19. Li J, Solus J, Chen Q, et al. Role of inﬂammation and oxidative stress in atrial ﬁbrillation. Heart Rhythm. 2010;7:438–44.

20. Shao Q, Chen K, Rha SW, et al. Usefulness of neutrophil/lymphocyte ratio as a predictor of atrial fibrillation: a meta-analysis. Arch Med Res. 2015;46:199-206.

21. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398-403.

22. Akgul O, Uyarel H, Pusuroglu H, et al. Prognostic value of elevated mean platelet volume in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Acta Cardiol. 2013;68:307-14.

23. Azab B, Torbey E, Sıngh J, et al. Mean platelet volume/platelet count ratio as a predictor of long –term mortality after non-ST-elevation myocardial infarction. Platelets. 2011;22:557–66.

24. David Gregg, Pascal J. Goldschmidt-Clermont. Platelets and Cardiovascular Disease. Circulation. 2003;108:e88-e90.

25. Chatterjee S, Bavishi C, Sardar P, et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am J Cardiol. 2014; 114:1049.